BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35660810)

  • 1. Metabolomics-based mass spectrometry methods to analyze the chemical content of 3D organoid models.
    Murphy SE; Sweedler JV
    Analyst; 2022 Jun; 147(13):2918-2929. PubMed ID: 35660810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in mass spectrometry based targeted metabolomics.
    Koal T; Deigner HP
    Curr Mol Med; 2010 Mar; 10(2):216-26. PubMed ID: 20196726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary Electrophoresis-Mass Spectrometry for Clinical Metabolomics.
    Ramautar R
    Adv Clin Chem; 2016; 74():1-34. PubMed ID: 27117659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CE-MS in metabolomics.
    Ramautar R; Somsen GW; de Jong GJ
    Electrophoresis; 2009 Jan; 30(1):276-91. PubMed ID: 19107702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods used to increase the comprehensive coverage of urinary and plasma metabolomes by MS.
    Chen Y; Xu J; Zhang R; Abliz Z
    Bioanalysis; 2016 May; 8(9):981-97. PubMed ID: 27079429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolome and mass spectrometry: new biomedical analysis perspectives].
    Chao De La Barca JM; Mirebeau-Prunier D; Moal V; Reynier P; Garnotel R; Simard G
    Ann Biol Clin (Paris); 2015; 73(1):126-30. PubMed ID: 25582729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrogation of the mammalian gut-brain axis using LC-MS/MS-based targeted metabolomics with in vitro bacterial and organoid cultures and in vivo gnotobiotic mouse models.
    Horvath TD; Haidacher SJ; Engevik MA; Luck B; Ruan W; Ihekweazu F; Bajaj M; Hoch KM; Oezguen N; Spinler JK; Versalovic J; Haag AM
    Nat Protoc; 2023 Feb; 18(2):490-529. PubMed ID: 36352124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored liquid chromatography-mass spectrometry analysis improves the coverage of the intracellular metabolome of HepaRG cells.
    Cuykx M; Negreira N; Beirnaert C; Van den Eede N; Rodrigues R; Vanhaecke T; Laukens K; Covaci A
    J Chromatogr A; 2017 Mar; 1487():168-178. PubMed ID: 28153450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming Sample Matrix Effect in Quantitative Blood Metabolomics Using Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry.
    Chen D; Han W; Su X; Li L; Li L
    Anal Chem; 2017 Sep; 89(17):9424-9431. PubMed ID: 28787119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass Accuracy Check Using Common Background Peaks for Improving Metabolome Data Quality in Chemical Isotope Labeling LC-MS.
    Li Y; Li L
    J Am Soc Mass Spectrom; 2019 Sep; 30(9):1733-1741. PubMed ID: 31140076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supercritical fluid chromatography - Mass spectrometry in metabolomics: Past, present, and future perspectives.
    van de Velde B; Guillarme D; Kohler I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1161():122444. PubMed ID: 33246285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based technologies for high-throughput metabolomics.
    Han J; Datla R; Chan S; Borchers CH
    Bioanalysis; 2009 Dec; 1(9):1665-84. PubMed ID: 21083110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large-scale analysis of targeted metabolomics data from heterogeneous biological samples provides insights into metabolite dynamics.
    Lee HJ; Kremer DM; Sajjakulnukit P; Zhang L; Lyssiotis CA
    Metabolomics; 2019 Jul; 15(7):103. PubMed ID: 31289941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-analytic evaluation of volumetric absorptive microsampling and integration in a mass spectrometry-based metabolomics workflow.
    Volani C; Caprioli G; Calderisi G; Sigurdsson BB; Rainer J; Gentilini I; Hicks AA; Pramstaller PP; Weiss G; Smarason SV; Paglia G
    Anal Bioanal Chem; 2017 Oct; 409(26):6263-6276. PubMed ID: 28815270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in mass spectrometry applied to pharmaceutical metabolomics.
    Drexler DM; Reily MD; Shipkova PA
    Anal Bioanal Chem; 2011 Mar; 399(8):2645-53. PubMed ID: 21107980
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.